Tenaya Therapeutics (TNYA) EPS (Weighted Average and Diluted) (2021 - 2026)
Tenaya Therapeutics' quarterly EPS (Weighted Average and Diluted) came in at -$0.09 in Q1 2026, up 62.5% year-on-year from -$0.06 in Q1 2025, and up 18.18% quarter-over-quarter from -$0.11 in Q4 2025.
Tenaya Therapeutics has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at -$0.09 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 62.5% year-over-year to -$0.09; the trailing twelve-month figure through Mar 2026 stood at -$0.46 (up 60.0% YoY), and the FY2025 full-year result was -$0.59, up 54.96% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.09, up from -$0.11 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.09 in Q1 2026, with the low at -$0.75 in Q1 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.38, with a median of -$0.39 recorded in 2023.
- Year-over-year, EPS (Weighted Average and Diluted) plunged 189.23% in 2022 and soared 62.5% in 2026.
- Tracing TNYA's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.58 in 2022, then surged by 31.03% to -$0.4 in 2023, then jumped by 32.5% to -$0.27 in 2024, then surged by 59.26% to -$0.11 in 2025, then advanced by 18.18% to -$0.09 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.09 (Q1 2026), -$0.11 (Q4 2025), and -$0.12 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.14 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | -0.39 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.58 |
| Sep 30, 2022 | -0.74 |
| Jun 30, 2022 | -0.69 |
| Mar 31, 2022 | -0.75 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | -0.68 |